Uncategorised - European Medical Journal

High Discontinuation Rates of GLP-1 RAs Among Patients Without Type 2 Diabetes

Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a year.

Challenges in Diagnosing and Managing Preschool Wheeze

The findings indicate that preschool wheeze has a profound impact on families, creating high levels of worry and restricting parents’ ability to work and travel.

Abemaciclib-Induced ILD Risk Explored

A recent prospective cohort study highlights the incidence and clinical course of abemaciclib-induced interstitial lung disease (ILD) in patients with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) previously treated with chemotherapy.

The latest edition of EMJ Innovations

The future of healthcare is here. From 3D-printed human anatomy to the metaverse in medicine, our latest Innovations journal explores…

Improving Clinic Capacity with Faricimab

This infographic summarises how clinic capacity may be improved with the use of faricimab…

Review of the Global Innovation and New Technology (GIANT) Health Event 2024

THE RAPID growth of healthcare innovation over the past year has driven transformative changes within the NHS and other government agencies…

Better Lungs Symposium at ERS 2024

There is an urgent need to elevate the importance of good lung health among patients, healthcare professionals, the general public, policy…

Scientific Innovations from 2024

The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in medicine in 2024…

Developments in Genitourinary Cancer Management: Shared Decision Making in Bladder and Kidney Cancers

At the European Society for Medical Oncology (ESMO) 2024, renowned experts, Michael Jewett, Andrea Necchi and Laurence Albiges discuss the…

Diagnostic and Surgical Challenges in Extradigital Glomus Tumour

Glomus tumours are uncommon, benign neoplasms originating from the glomus body, predominantly affecting adults between 20–40 years of age…